|
1
|
Ogino S, Galon J, Fuchs CS and Dranoff G:
Cancer immunology-analysis of host and tumor factors for
personalized medicine. Nat Rev Clin Oncol. 8:711–719. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Borghaei H, Smith MR and Campbell KS:
Immunotherapy of cancer. Eur J Pharmacol. 625:41–54. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chiang CL, Coukos G and Kandalaft LE:
Whole tumor antigen vaccines: Where are we? Vaccines (Basel).
3:344–372. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
González FE, Gleisner A, Falcón-Beas F,
Osorio F, López MN and Salazar-Onfray F: Tumor cell lysates as
immunogenic sources for cancer vaccine design. Hum Vaccin
Immunother. 10:3261–3269. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Son CH, Bae JH, Shin DY, Lee HR, Yang K
and Park YS: Antitumor effect of dendritic cell loaded ex vivo and
in vivo with tumor-associated antigens in lung cancermodel. Immunol
Invest. 43:447–462. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dong B, Sun L, Wu X, Zhang P and Wang L,
Wei H, Zhou L, Hu X, Yu Y, Hua S and Wang L: Vaccination with TCL
plus MHSP65 induces anti-lung cancer immunity in mice. Cancer
Immunol Immunother. 59:899–908. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li JJ and Xie D: RACK1, a versatile hub in
cancer. Oncogene. 34:1890–1898. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shi S, Deng YZ, Zhao JS, Ji XD, Shi J,
Feng YX, Li G, Li JJ, Zhu D, Koeffler HP, et al: RACK1 promotes
non-small-cell lung cancer tumorigenicity through activating sonic
hedgehog signaling pathway. J Biol Chem. 287:7845–7858. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huhn S, Ingelfinger D, Bermejo JL, Bevier
M, Pardini B, Naccarati A, Steinke V, Rahner N, Holinski-Feder E,
Morak M, et al: Polymorphisms in CTNNBL1 in relation to colorectal
cancer with evolutionary implications. Int J Mol Epidemiol Genet.
2:36–50. 2011.PubMed/NCBI
|
|
10
|
van Maldegem F, Maslen S, Johnson CM,
Chandra A, Ganesh K, Skehel M and Rada C: CTNNBL1 facilitates the
association of CWC15 with CDC5L and is required to maintain the
abundance of the Prp19 spliceosomal complex. Nucleic Acids Res.
43:7058–7069. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ganesh K, Adam S, Taylor B, Simpson P,
Rada C and Neuberger M: CTNNBL1 is a novel nuclear localization
sequence-binding protein that recognizes RNA-splicing factors CDC5L
and Prp31. J Biol Chem. 286:17091–17102. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Conticello SG, Ganesh K, Xue K, Lu M, Rada
C and Neuberger MS: Interaction between antibody-diversification
enzyme AID and spliceosome-associated factor CTNNBL1. Mol Cell.
31:474–484. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Svec D, Tichopad A, Novosadova V, Pfaffl
MW and Kubista M: How good is a PCR efficiency estimate:
Recommendations for precise and robust qPCR efficiency assessments.
Biomol Detect Quantif. 3:9–16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dorr C, Janik C, Weg M, Been RA, Bader J,
Kang R, Ng B, Foran L, Landman SR, O'Sullivan MG, et al: Transposon
mutagenesis screen identifies potential lung cancer drivers and
CUL3 as a tumor suppressor. Mol Cancer Res. 13:1238–1247. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou X, Li X, Cheng Y, Wu W, Xie Z, Xi Q,
Han J, Wu G, Fang J and Feng Y: BCLAF1 and its splicing regulator
SRSF10 regulate the tumorigenic potential of colon cancer cells.
Nat Commun. 5:45812014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Knoll M, Macher-Goeppinger S, Kopitz J,
Duensing S, Pahernik S, Hohenfellner M, Schirmacher P and Roth W:
The ribosomal protein S6 in renal cell carcinoma: Functional
relevance and potential as biomarker. Oncotarget. 7:418–432. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Skrzycki M, Czeczot H, Chrzanowska A and
Otto-Ślusarczyk D: The level of superoxide dismutase expression in
primary and metastatic colorectal cancer cells in hypoxia and
tissue normoxia. Pol Merkur Lekarski. 39:281–286. 2015.(In Polish).
PubMed/NCBI
|
|
19
|
Sharma S, Evans A and Hemers E:
Mesenchymal-epithelial signalling in tumour microenvironment: Role
of high-mobility group Box 1. Cell Tissue Res. 365:357–366. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Han X, Chen Y, Yao N, Liu H and Wang Z:
MicroRNA let-7b suppresses human gastric cancer malignancy by
targeting ING1. Cancer Gene Ther. 22:122–129. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Terashita Y, Ishiguro H, Haruki N, Sugiura
H, Tanaka T, Kimura M, Shinoda N, Kuwabara Y and Fujii Y: Excision
repair cross complementing 3 expression is involved in patient
prognosis and tumor progression in esophageal cancer. Oncol Rep.
12:827–831. 2004.PubMed/NCBI
|
|
22
|
Kawahara M and Takaku H: A tumor lysate is
an effective vaccine antigen for the stimulation of CD4(+) T-cell
function and subsequent induction of antitumor immunity mediated by
CD8(+) T cells. Cancer Biol Ther. 16:1616–1625. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gershan JA, Barr KM, Weber JJ, Jing W and
Johnson BD: Immune modulating effects of cyclophosphamide and
treatment with tumor lysate/CpG synergize to eliminate murine
neuroblastoma. J Immunother Cancer. 3:242015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yuan X, Li W, Cui Y, Zhan Q, Zhang C, Yang
Z, Li X, Li S, Guan Q and Sun X: Specific cellular immune response
elicited by the necrotic tumor cell-stimulated macrophages. Int
Immunopharmacol. 27:171–176. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang DL: The role of scaffold RACK1 in
the production of proinflammatory cytokines [Dissertation]. Guang
Zhou: Zhongnan University; 2013
|
|
26
|
O'Neill LA and Pearce EJ: Immunometabolism
governs dendritic cell and macrophage function. J Exp Med.
213:15–23. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cybulsky MI, Cheong C and Robbins CS:
Macrophages and dendritic cells: Partners in atherogenesis. Circ
Res. 118:637–652. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Y, Shen JY, Luo L and Yin ZM: The
Location of FITC-GSTP1 in the Murine Macrophages. J Nanjing Norm
Univ (Nat Sci Ed). 1–110. 2008.
|
|
29
|
Wirsdörfer F, Bangen JM, Pastille E,
Schmitz D, Flohé S, Schumak B and Flohé SB: Dendritic cell-like
cells accumulate in regenerating murine skeletal muscle after
injury and boost adaptive immune responses only upon a microbial
challenge. PLoS One. 11:e01558702016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wennhold K, Weber TM, Klein-Gonzalez N,
Thelen M, Garcia-Marquez M, Chakupurakal G, Fiedler A, Schlösser
HA, Fischer R, Theurich S, et al: CD40-activated B cells induce
anti-tumor immunity in vivo. Oncotarget. 8:27740–27753.
2017.PubMed/NCBI
|
